{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T14:02:27Z","timestamp":1789221747854,"version":"build-2803163510"},"reference-count":26,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20H03715"],"award-info":[{"award-number":["20H03715"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004169","name":"Meiji Seika Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004169","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Risk\u2010adapted therapy is recommended to prevent major clinical complications, such as thrombo\u2010haemorrhagic events, in patients with essential thrombocythaemia (ET). In this study, we analysed the association between non\u2010driver gene mutations and thrombo\u2010haemorrhagic events in 579 patients with ET. <jats:italic>ASXL1<\/jats:italic> and <jats:italic>TP53<\/jats:italic> mutations were frequently identified in patients with ET complicated by thrombosis (22.7% and 23.1%, respectively), and the <jats:italic>DNMT3A<\/jats:italic> mutation was frequently identified in patients who experienced haemorrhage (15.2%). Multivariate analyses of thrombosis\u2010free survival (TFS) revealed that <jats:italic>ASXL1<\/jats:italic> and <jats:italic>TP53<\/jats:italic> mutations are associated with thrombosis (hazard ratio [HR]\u2009=\u20093.140 and 3.752 respectively). Patients harbouring the <jats:italic>ASXL1<\/jats:italic> or <jats:italic>TP53<\/jats:italic> mutation had significantly worse TFS rates than those without mutation (<jats:italic>p<\/jats:italic>\u2009=\u20090.002 and <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 respectively). Furthermore, <jats:italic>JAK2<\/jats:italic>V617F\u2010mutated patients with accompanying <jats:italic>ASXL1<\/jats:italic> mutations showed significantly shorter TFS compared with those without <jats:italic>ASXL1<\/jats:italic> mutations (<jats:italic>p<\/jats:italic>\u2009=\u20090.003). Multivariate analyses of haemorrhage\u2010free survival (HFS) revealed that the <jats:italic>DNMT3A<\/jats:italic> mutation (HR\u2009=\u20092.784) is associated with haemorrhage. <jats:italic>DNMT3A\u2010<\/jats:italic>mutated patients showed significantly shorter HFS than those without the mutation (<jats:italic>p<\/jats:italic>\u2009=\u20090.026). Non\u2010driver gene mutations should be considered in treatment strategies and may provide important information for personalised treatment approaches.<\/jats:p>","DOI":"10.1111\/bjh.19177","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T01:35:03Z","timestamp":1698975303000},"page":"221-228","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Impact of non\u2010driver gene mutations on thrombo\u2010haemorrhagic events in <scp>ET<\/scp> patients"],"prefix":"10.1111","volume":"204","author":[{"given":"Chiho","family":"Furuya","sequence":"first","affiliation":[{"name":"Department of Hematology Juntendo University Graduate School of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1081-0130","authenticated-orcid":false,"given":"Soji","family":"Morishita","sequence":"additional","affiliation":[{"name":"Department of Advanced Hematology Juntendo University Graduate School of Medicine  Tokyo Japan"},{"name":"Laboratory for the Development of Therapies Against MPN Juntendo University Graduate School of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3374-9814","authenticated-orcid":false,"given":"Yoshinori","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Advanced Hematology Juntendo University Graduate School of Medicine  Tokyo Japan"},{"name":"Department of Hematology Tottori Prefectural Central Hospital  Tottori Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9618-6588","authenticated-orcid":false,"given":"Tadaaki","family":"Inano","sequence":"additional","affiliation":[{"name":"Department of Hematology Juntendo University Graduate School of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6156-4211","authenticated-orcid":false,"given":"Tomonori","family":"Ochiai","sequence":"additional","affiliation":[{"name":"Department of Hematology Juntendo University Graduate School of Medicine  Tokyo Japan"},{"name":"Department of Advanced Hematology Juntendo University Graduate School of Medicine  Tokyo Japan"},{"name":"Laboratory for the Development of Therapies Against MPN Juntendo University Graduate School of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Shirane","sequence":"additional","affiliation":[{"name":"Department of Hematology Juntendo University Graduate School of Medicine  Tokyo Japan"},{"name":"Department of Advanced Hematology Juntendo University Graduate School of Medicine  Tokyo Japan"},{"name":"Laboratory for the Development of Therapies Against MPN Juntendo University Graduate School of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8386-1871","authenticated-orcid":false,"given":"Yoko","family":"Edahiro","sequence":"additional","affiliation":[{"name":"Department of Hematology Juntendo University Graduate School of Medicine  Tokyo Japan"},{"name":"Department of Advanced Hematology Juntendo University Graduate School of Medicine  Tokyo Japan"},{"name":"Laboratory for the Development of Therapies Against MPN Juntendo University Graduate School of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3502-5000","authenticated-orcid":false,"given":"Marito","family":"Araki","sequence":"additional","affiliation":[{"name":"Department of Advanced Hematology Juntendo University Graduate School of Medicine  Tokyo Japan"},{"name":"Laboratory for the Development of Therapies Against MPN Juntendo University Graduate School of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8871-1330","authenticated-orcid":false,"given":"Miki","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Hematology Juntendo University Graduate School of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1880-9126","authenticated-orcid":false,"given":"Norio","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Department of Hematology Juntendo University Graduate School of Medicine  Tokyo Japan"},{"name":"Department of Advanced Hematology Juntendo University Graduate School of Medicine  Tokyo Japan"},{"name":"Laboratory for the Development of Therapies Against MPN Juntendo University Graduate School of Medicine  Tokyo Japan"},{"name":"PharmaEssentia Japan KK  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2014.07.268"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1816082"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-017-3082-y"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-444067"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.94"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24293"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1720979"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-021-04617-6"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2023.2229131"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26332"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.119"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.78.9867"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16380"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2016000216"},{"issue":"5","key":"e_1_2_12_16_1","first-page":"4149","article-title":"ASXL1 mutations in Chinese patients with essential thrombocythemia","volume":"15","author":"Nie YB","year":"2018","journal-title":"Exp Ther Med"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00470-y"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544"},{"key":"e_1_2_12_19_1","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow SH","year":"2017"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13882"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.244"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040934"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-017-0035-6"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1701719"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01935"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05408-1"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012536"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.19177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T06:56:50Z","timestamp":1760079410000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.19177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1111\/bjh.19177"],"URL":"https:\/\/doi.org\/10.1111\/bjh.19177","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]},"assertion":[{"value":"2023-08-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}